MFS
MRNS

MSI Financial Services’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

MSI Financial Services’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-250
Closed -$8K – 3982
2015
Q3 		$8K Buy
+250
New +$14.1K ﹤0.01% 2200

Other funds holding MRNS

CPV
Canaan Partners VII Westport, Connecticut $32.3M AUM 154.97% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

MSI Financial Services's MRNS Position: Q4 2015 in Review

MSI Financial Services sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q4 2015, closing a stake of 250 shares — an estimated $8K sold.

MSI Financial Services first reported a position in MRNS in Q3 2015 and held it in 1 quarter. The position peaked at $8K in Q3 2015. 38 funds tracked by Wall St. Rank hold MRNS as of Q4 2015.

  • MSI Financial Services reported no remaining Marinus Pharmaceuticals, Inc position as of Q4 2015 after selling out during the quarter.
  • MSI Financial Services sold 250 Marinus Pharmaceuticals, Inc shares in Q4 2015, an estimated $8K.
  • MSI Financial Services first reported a position in Marinus Pharmaceuticals, Inc in Q3 2015 and held it in 1 quarter.
  • MSI Financial Services's Marinus Pharmaceuticals, Inc position peaked at $8K in Q3 2015.
  • 38 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q4 2015.

Based on MSI Financial Services's 13F filing for Q4 2015, filed 4 Feb 2016.